Clinical Trial Update: Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial [NA]

View source ↗

Summary

Clinical trial update on the Firebird2 cobalt-chromium alloyed sirolimus-eluting stent registry for coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Firebird2 Sirolimus-Eluting Stent (Sirolimus-eluting stent)

Snippet

Sponsor: Shanghai MicroPort Medical (Group) Co., Ltd. | Conditions: Coronary Heart Disease | NA | Status: UNKNOWN